vs
Side-by-side financial comparison of GILAT SATELLITE NETWORKS LTD (GILT) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $152.7M, roughly 1.1× GILAT SATELLITE NETWORKS LTD). GILAT SATELLITE NETWORKS LTD runs the higher net margin — 4.1% vs -82.0%, a 86.1% gap on every dollar of revenue.
Gilat Satellite Networks Ltd. is an Israeli public company. It provides satellite-based broadband communications technology, its main expertise being the development, manufacture, and marketing of ground-based satellite systems for global communication via satellites.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
GILT vs PTCT — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $152.7M | $164.7M |
| Net Profit | $6.3M | $-135.0M |
| Gross Margin | 35.8% | — |
| Operating Margin | 5.4% | -43.3% |
| Net Margin | 4.1% | -82.0% |
| Revenue YoY | — | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | $57016808.00 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $164.7M | ||
| Q3 25 | — | $211.0M | ||
| Q2 25 | $152.7M | $178.9M | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $213.2M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | $126.6M | $186.7M | ||
| Q1 24 | — | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | $6.3M | $-64.8M | ||
| Q1 25 | — | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | — | $-106.7M | ||
| Q2 24 | $9.9M | $-99.2M | ||
| Q1 24 | — | $-91.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 35.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 39.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -43.3% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | 5.4% | -19.5% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | 9.8% | -21.5% | ||
| Q1 24 | — | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | — | 7.5% | ||
| Q2 25 | 4.1% | -36.3% | ||
| Q1 25 | — | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | — | -54.2% | ||
| Q2 24 | 7.8% | -53.1% | ||
| Q1 24 | — | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | — | $0.20 | ||
| Q2 25 | $57016808.00 | $-0.83 | ||
| Q1 25 | — | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | — | $-1.39 | ||
| Q2 24 | $56622204.00 | $-1.29 | ||
| Q1 24 | — | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $1.9B |
| Total DebtLower is stronger | $56.5M | — |
| Stockholders' EquityBook value | $315.8M | $-205.3M |
| Total Assets | $575.9M | $2.9B |
| Debt / EquityLower = less leverage | 0.18× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $64.9M | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | $93.7M | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $56.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-205.3M | ||
| Q3 25 | — | $-155.8M | ||
| Q2 25 | $315.8M | $-206.5M | ||
| Q1 25 | — | $-185.8M | ||
| Q4 24 | — | $-1.1B | ||
| Q3 24 | — | $-1.1B | ||
| Q2 24 | $282.8M | $-980.2M | ||
| Q1 24 | — | $-893.9M |
| Q4 25 | — | $2.9B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | $575.9M | $2.6B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | $416.9M | $1.9B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.3M | ||
| Q3 25 | — | $-66.3M | ||
| Q2 25 | — | $-58.3M | ||
| Q1 25 | — | $870.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | — | $-77.0M | ||
| Q2 24 | $8.2M | $-71.5M | ||
| Q1 24 | — | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | $1.7M | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | 1.3% | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | 5.2% | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
